Alvotech and Teva Announce U.S. FDA Approval of Additional Presentation of SELARSDI™ (ustekinumab-aekn), Expanding its Label to Include Further Indications Approved for Reference Product, Stelara® (ustekinumab) 22-10-2024, 18:00

Fortrea Completes Expansion of Clinical Pharmacology Solutions Following Targeted Investments at its Four Clinical Research Units in U.S. and U.K. 2-11-2023, 18:00

Pico Projector Market Size to Hit USD 8.9 Billion at a CAGR 14-03-2023, 13:02